Listing

  1. Published!
  2. The Neuro4D Conference
  3. Psychedelic Therapeutics and Drug Development Conference
  4. New poster added to our publications page, recently presented at ADPD!
  5. New poster added to our publications page, recently presented at FENS
  6. FENS Regional Meeting 2023
  7. Neuroimmunology Drug Development Summit
  8. New clients, different time zones
  9. AD/PD 2023
  10. OARSI World Congress
  11. Veterinary Meeting and Expo
  12. Dr. Pabitra H. Patra paper published in PAIN
  13. New published work!
  14. Name change announcement, news from the CEO
  15. CNS Therapeutic Xchange Europe 2022, Zurich - 24th November
  16. Society for Neuroscience 2022, November 12-16, California
  17. Here, there and everywhere - we love meeting up with you!
  18. ECNP Congress, 15th-18th October - Vienna, Austria
  19. Recent collaborative work published by Frontiers in Molecular Neuroscience
  20. Animals in scientific research, 7th Annual Conference, by PolLASA. 12-14th September, Warsaw, Poland
  21. IASP World Conference on Pain - Toronto, Canada, 19th - 23rd September
  22. Global representation meeting the needs of our worldwide client base
  23. HubXchange's US West Coast CNS Therapeutics Meeting - 29th September
  24. The Safety Pharmacology Society Annual Meeting - September 11-14, Montréal, Canada
  25. Rapid access to canine preclinical studies and leading PK expertise
  26. Collaboration between Zebrafish Lab and Transpharmation continues
  27. 5th Polish Zebrafish Society Workshop in Lublin (Poland) 29th June - 1st July
  28. Progressive Ratio Task reveals effectiveness of single-dose psilocybin
  29. BPS live! Rapid acting antidepressants, from ketamine to psychedelics TUESDAY 10TH, 17TH AND 24TH MAY, 2PM (BST)
  30. The Neuro4D Conference 2022, Mainz, Germany, 16th - 17th May 2022
  31. SMi’s 22nd Annual Conference; Pain Therapeutics, 4 - 5 May, 2022, London
  32. Long term and delayed effects of psychedelics in preclinical models
  33. ADPD, 16th International Conference on Alzheimer's Disease and Parkinson's Disease – 15 - 20 March 2022
  34. Transpharmation’s Facilities Management Company receive AAALAC accreditation
  35. Fierce Biotech report on Transpharmation and InterVivo's joint venture
  36. InterVivo Solutions and Transpharmation join forces as sister companies
  37. Zebrafish as a translational model for neuroscience research
  38. HubXchange - CNS Therapeutics Xchange Europe 2021 – 2nd December 2021
  39. The Society for Neuroscience 50th Annual Meeting will be fully virtual - 8-11 November
  40. 34th ECNP Congress Hybrid - Lisbon, Portugal - 2nd - 5th October 2021
  41. Neurex Neuroforum 2021
  42. Cannabinoids and Psychedelics; Neuroscience Ireland Meeting 2021 - 9th-10th September 2021
  43. UK scientists at Transpharmation and Clerkenwell Health combine lab and human trials, as psilocybin offers hope for people with an end-of-life diagnosis
  44. FENS Regional Meeting (FRM) - 25-27 August 2021
  45. InterVivo Solutions Provides Update on Cooperative Psychedelics Evaluation Platform (COPE)
  46. 31st Annual International Cannabinoid Research Society (ICRS) Virtual Symposium on Cannabinoids - 21-24 June 2021
  47. Let us inspire you!
  48. Transpharmation Ireland gains Green Labs certification
  49. Transpharmation’s pain expertise recognised
  50. HubXchange's US East Coast CNS Therapeutics e-Xchange Virtual meeting - 24-26 May 2021
  51. ICNMD – 16th International Congress on Neuromuscular Diseases Digital 2021 - 21-22 & 28-29 May 2021
  52. SMi - 21st Annual Conference Pain Therapeutics Virtual conference - 10-11 of May 2021
  53. BNA 2021 - British Neuroscience Association - Festival of Neuroscience 2021 Virtual Conference 12-15 April 2021
  54. 3rd Annual Neuroimmunology Drug Development Summit 2021 Virtual Conference – 27-29 April 2021
  55. “Companies have no borders”, said Mark Duxon, CEO of Transpharmation
  56. ADPD, 15th International Conference on Alzheimer's Disease and Parkinson's Disease – 9-14 March 2021
  57. New Laboratory
  58. InterVivo Solutions Issued Institutional Cannabis Research License By Health Canada
  59. ASENT - American Society of Experimental Neurotherapeutics 2021 Virtual Conference 22-25 of February 2021
  60. Peer Review Journal Publication
  61. Society for Neuroscience (SfN) digital event 11-13th January 2021
  62. Neuronus 2020 IBRO neuroscience forum - 8th - 11th December 2020
  63. Transpharmation’s expansion to world class facilities!
  64. Young Investigator Symposium, 6th November 2020
  65. Inflammasome Therapeutics Summit - 4th - 6th November 2020
  66. Ten year anniversary!
  67. WMS virtual conference - 28th September – 2nd October 2020
  68. Alzheimer’s Drug Discovery Foundation (ADDF) - 5th and 6th October 2020
  69. IASP
  70. 33rd ENCP Congress - 12th - 15th September 2020
  71. 2nd Neuroimmunology Drug Discovery Summit, digital event - 5-7th August 2020
  72. BIND Project
  73. Congratulation to Transpharmation's Dr. Jack Prenderville
  74. AAIC - Alzheimer’s Association International Conference - 27th July 2020
  75. New Parkinson's disease enterprise partnership with Trinity College Institute of Neuroscience
  76. SMi's 20th Annual Pain Therapeutics Conference 11th May to 12th May 2020
  77. Covid-19 update: April
  78. IASP Virtual Pain Series and Expo - September 2020 - March 2021
  79. Company of the year!
  80. Transpharmation Ltd are one of the partners to receive the prestigious Horizon 2020 Grant
  81. Advancing preclinical neuropathic pain research
  82. Trinity College Institute of Neuroscience Seminar Series 2019
  83. Don't miss out!
  84. Have you downloaded our recent work?
  85. BioEurope Hamburg 2019 (booth 166)
  86. Society for Neuroscience 2019 (booth 1810)